TNF-α drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice

被引:168
作者
Baluk, Peter [1 ,2 ]
Yao, Li-Chin [1 ,2 ]
Feng, Jennifer [1 ,2 ]
Romano, Talia [1 ,2 ]
Jung, Sonia S. [3 ,4 ]
Schreiter, Jessica L. [3 ,4 ]
Yan, Li [3 ,4 ]
Shealy, David J. [3 ,4 ]
McDonald, Donald M. [1 ,2 ]
机构
[1] Univ Calif San Francisco, Cardiovasc Res Inst, Ctr Comprehens Canc, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
[3] Centocor Res & Dev Inc, Dept Oncol, Radnor, PA USA
[4] Centocor Res & Dev Inc, Dept Immunol, Radnor, PA USA
关键词
TUMOR-NECROSIS-FACTOR; ENDOTHELIAL GROWTH-FACTOR; ESCHERICHIA-COLI PNEUMONIA; GENE-EXPRESSION; IN-VIVO; PROINFLAMMATORY CYTOKINES; INDUCED ANGIOGENESIS; MYCOPLASMA-PULMONIS; DEFICIENT MICE; CELLS;
D O I
10.1172/JCI37626
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Inflammation is associated with blood vessel and lymphatic vessel proliferation and remodeling. The microvasculature of the mouse trachea provides an ideal opportunity to study this process, as Mycoplasma pulmonis infection of mouse airways induces widespread and sustained vessel remodeling, including enlargement of capillaries into venules and lymphangiogenesis. Although the mediators responsible for these vascular changes in mice have not been identified, VEGF-A is known not to be involved. Here, we sought to determine whether TNF-alpha drives the changes in blood vessels and lymphatics in M. pulmonis-infected mice. The endothelial cells, but not pericytes, of blood vessels, but not lymphatics, were immunoreactive for TNF receptor 1 (TNF-R1) and lymphotoxin B receptors. Most TNF-R2 immunoreactivity was on leukocytes. Infection resulted in a large and sustained increase in TNF-alpha expression, as measured by real-time quantitative RT-PCR, and smaller increases in lymphotoxins and TNF receptors that preceded vessel remodeling. Substantially less vessel remodeling and lymphangiogenesis occurred when TNF-alpha signaling was inhibited by a blocking antibody or was silenced in Tnfr1(-/-) mice. When administered after infection was established, the TNF-alpha-specific antibody slowed but did not reverse blood vessel remodeling and lymphangiogenesis. The action of TNF-alpha on blood vessels is probably mediated through direct effects on endothelial cells, but its effects on lymphangiogenesis may require inflammatory mediators from recruited leukocytes. We conclude that TNF-alpha is a strong candidate for a mediator that drives blood vessel remodeling and lymphangiogenesis in inflammation.
引用
收藏
页码:2954 / 2964
页数:11
相关论文
共 73 条
[1]   Signalling pathways of the TNF superfamily: A double-edged sword [J].
Aggarwal, BB .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (09) :745-756
[2]   Immune complex-dependent remodeling of the airway vasculature in response to a chronic bacterial infection [J].
Aurora, AB ;
Baluk, P ;
Zhang, DJ ;
Sidhu, SS ;
Dolganov, GM ;
Basbaum, C ;
McDonald, DM ;
Killeen, N .
JOURNAL OF IMMUNOLOGY, 2005, 175 (10) :6319-6326
[3]   Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation [J].
Baluk, P ;
Tammela, T ;
Ator, E ;
Lyubynska, N ;
Achen, MG ;
Hicklin, DJ ;
Jeltsch, M ;
Petrova, TV ;
Pytowski, B ;
Stacker, SA ;
Ylä-Herttuala, S ;
Jackson, DG ;
Alitalo, K ;
McDonald, DM .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) :247-257
[4]   Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways [J].
Baluk, P ;
Lee, CG ;
Link, H ;
Ator, E ;
Haskell, A ;
Elias, JA ;
McDonald, DM .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (04) :1071-1085
[5]   Functionally specialized junctions between endothelial cells of lymphatic vessels [J].
Baluk, Peter ;
Fuxe, Jonas ;
Hashizume, Hiroya ;
Romano, Talia ;
Lashnits, Erin ;
Butz, Stefan ;
Vestweber, Dietmar ;
Corada, Monica ;
Molendini, Cinzia ;
Dejana, Elisabetta ;
McDonald, Donald M. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (10) :2349-2362
[6]   Impaired inflammatory angiogenesis, but not leukocyte influx, in mice lacking TNFR1 [J].
Barcelos, LS ;
Talvani, A ;
Teixeira, AS ;
Vieira, LQ ;
Cassali, GD ;
Andrade, SP ;
Teixeira, MM .
JOURNAL OF LEUKOCYTE BIOLOGY, 2005, 78 (02) :352-358
[7]   Cytokine-directed therapies for the treatment of chronic airway diseases [J].
Barnes, PJ .
CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (06) :511-522
[8]   Evidence of a role of tumor necrosis factor α in refractory asthma [J].
Berry, MA ;
Hargadon, B ;
Shelley, M ;
Parker, D ;
Shaw, DE ;
Green, RH ;
Bradding, P ;
Brightling, CE ;
Wardlaw, AJ ;
Pavord, ID .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (07) :697-708
[9]   TNF-α in asthma [J].
Berry, Mike ;
Brightling, Christopher ;
Pavord, Ian ;
Wardlaw, A. J. .
CURRENT OPINION IN PHARMACOLOGY, 2007, 7 (03) :279-282
[10]   ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in the setting of inflammation [J].
Brown, C ;
Gaspar, J ;
Pettit, A ;
Lee, R ;
Gu, XS ;
Wang, H ;
Manning, C ;
Voland, C ;
Goldring, SR ;
Goldring, MB ;
Libermann, TA ;
Gravallese, EM ;
Oettgen, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12794-12803